oral glp-1 drugs Patients taking an experimental drug lost significant weight and improved heart and metabolic risk factors in a large, worldwide phase 3 clinical trial led by Weill Cornell Medicine and other Novo Nordisk's oral GLP-1 drug
Pay in 4 interest-free payments of $7.18 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16




























